US10987032B2 - Method, system, and apparatus for remotely controlling and monitoring an electronic device - Google Patents

Method, system, and apparatus for remotely controlling and monitoring an electronic device Download PDF

Info

Publication number
US10987032B2
US10987032B2 US15/285,774 US201615285774A US10987032B2 US 10987032 B2 US10987032 B2 US 10987032B2 US 201615285774 A US201615285774 A US 201615285774A US 10987032 B2 US10987032 B2 US 10987032B2
Authority
US
United States
Prior art keywords
patient
medical device
electronic
electronic device
remote party
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/285,774
Other languages
English (en)
Other versions
US20180092576A1 (en
Inventor
Cláudio Afonso Ambrósio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US15/285,774 priority Critical patent/US10987032B2/en
Priority to EP17857709.4A priority patent/EP3522950A4/fr
Priority to PCT/BR2017/050217 priority patent/WO2018064733A1/fr
Priority to BR112019006808A priority patent/BR112019006808A2/pt
Publication of US20180092576A1 publication Critical patent/US20180092576A1/en
Application granted granted Critical
Publication of US10987032B2 publication Critical patent/US10987032B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/7465—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G16H10/65—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
    • H04L67/125—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks involving control of end-device applications over a network
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04W—WIRELESS COMMUNICATION NETWORKS
    • H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
    • H04W4/02—Services making use of location information
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04W—WIRELESS COMMUNICATION NETWORKS
    • H04W4/00—Services specially adapted for wireless communication networks; Facilities therefor
    • H04W4/02—Services making use of location information
    • H04W4/029—Location-based management or tracking services
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program

Definitions

  • the disclosed subject matter relates generally to electronic devices and, more particularly, to electronic devices configured to wirelessly communicate with and receive remote instructions to initiate operation from another remote electronic device.
  • Wearable drug delivery systems are known in the art for treating and managing chronic and/or terminal medical conditions. Such systems and apparatuses increase quality of life for patients who may otherwise be forced to focus their attention and energy on monitoring the state of their condition. For instance, it is well known that some conditions, such as diabetes, require patients to monitor their own blood glucose levels throughout the day and, in response to certain low or high measurements, consume or inject prescribed amounts of carbohydrates or alternatively inject prescribed amounts of insulin. Indeed, it is well known that the delivered volume of any of these treatments depends on the specific amount of sugar in the blood. Ensuring timely and effective delivery of a treatment is often dependent on various factors susceptible to daily or hourly fluctuation. As a result, patients often work closely with their physicians and even close acquaintances to manage their condition.
  • hypoglycemia is a condition in which patients have abnormally low blood glucose levels. This often occurs in conjunction with glucose circulation conditions such as diabetes. Because symptoms of hypoglycemia—including nervousness, anxiety, impatience, irritability, confusion, physical weakness, fatigue, and even unconsciousness—are usually present in a patient after the patient's blood glucose levels have already fallen well below healthy levels, patients are often unable to tell in advance when they are going to experience a hypoglycemic episode. Thus patients are often rendered incapable of effectively caring for themselves, and fail to stop insulin delivery and/or begin delivering glucose to their body through the prescribed methods when the symptoms occur. This can be particularly problematic because untimely treated hypoglycemic episodes are known to have dire consequences.
  • symptoms such as dizziness and blurred and impaired vision have been known to cause traffic accidents when they occur while driving.
  • patients can experience hypoglycemic coma and even death if they fail to timely treat the condition with effective amounts of prescribed treatments. This can particularly dangerous in the event that a patient experiences unexpected changes to his or her condition and is unable to address it themselves, whether on account of the nature of their current treatment plan or incapacitation.
  • the present disclosure is directed to systems, methods, and apparatuses for electronically requesting therapeutic response from a remote location. More particularly, the disclosure is directed to an electronic device having an electronic control circuit configured to receive remote, wireless instructions from an electronic device, such a computer or cellphone, controlled by a remote party chosen from among a patient's personal contacts and/or caregivers. It is contemplated that the remote party may use their electronic device to, in some embodiments, communicate instructions causing the electronic control circuit housed in the medical device to optionally activate or deactivate such medical device, effectively treating the patient from a remote location.
  • the medical device may be configured to collect and wirelessly communicate various bodily data characterizing the patient's condition. The medical device may be operative to continuously, periodically, or even manually transmit such data to the personal electronic devices respective of each of one or more pre-selected remote parties.
  • the medical device is an infusion pump, known to those skilled in the art.
  • Such pumps wearable by a patient and known by those skilled in the art to deliver therapeutic doses of prescribed medication via a cannula inserted in the patient.
  • Such pumps may be programmed to automatically deliver doses of prescribed medication into the body of the patient at regular intervals, deliver doses of prescribed medication upon electronically communicated receipt of information regarding threshold patient conditions, or even be manually instructed to deliver such dosages by the patient or caregiver.
  • the medical device is any insulin pump such as those commonly prescribed for use by diabetic patients.
  • the medical device may be a glucose monitor also commonly prescribed to diabetic patients, or others having chronic metabolic conditions.
  • the medical device is a combination of the two and may even further comprise a glucose or Glucagon pump. It is contemplated, though, and one skilled in the art will recognize, that the invention may be practiced with any of the aforementioned medical devices, a combination of the same, or any of those that may be developed as the field of electronic wearable medical devices continues to improve so long as it is capable of wireless communication with one or more personal electronic devices as discussed in further detail below.
  • the electronic control circuit may be contained in a device other than an electronic wearable medical device.
  • various household electronics such as a television, air conditioning system, watering or sprinkler system, security system may be configured to receive remote, wireless instructions from a personal electronic device, such as a computer or cellphone.
  • a medical device is described for the sake of brevity and in the interest of enabling the technology only.
  • a party in possession of a personal electronic device may use the device to, in some embodiments, communicate instructions causing an electronic control circuit housed in another device, such as another personal electronic device or even household electronic device, to optionally activate or deactivate the personal or household electronic device.
  • the personal or household device may be configured to wirelessly communicate various conditions, which may be continuously, periodically, or manually transmitted by the personal or household device to the personal electronic devices respective of each of one or more pre-selected party.
  • the personal or household devices may communicate whether such personal or household devices are powered on or off to one or more pre-selected parties' device.
  • the electronic control circuit of the medical device may be activated to deliver a therapeutic dose of a prescribed drug by instructions communicated via the one or more of the personal electronic devices.
  • the medical device may further be configured as a wireless data transmitter capable of communicating a patient's condition through various communication networks.
  • the medical device comprises a blood glucose monitor and pump
  • the medical device may periodically report the patient's particular blood glucose levels to any personal electronic devices that have been communicatively linked to the medical device. Having received a report of the patient's condition along with a request from the patient for remote treatment, then, a remote party may use their electronic device, communicatively linked with the medical device, to transmit instructions activating the medical device.
  • the medical device may be configured to be capable of communicatively linking wirelessly to various electronic devices via Wi-Fi, Bluetooth, cellular data or any other communication network available to read and carry out portable commands transmitted from such personal electronic devices.
  • the medical device may communicate over digital cellular networks used by mobile phones such as GSM, cellular communication data services such as GPRS, and satellite systems such as GPS.
  • GSM Global System for Mobile communications
  • GPRS cellular communication data services
  • GPS satellite systems
  • the one or more electronic devices wirelessly and communicatively linkable to the medical device may be chosen from any of a personal, laptop, or tablet computer; and land line or mobile telephone, cell phone, or smart phone. Indeed, it is contemplated that any desirable party may be granted access to communicate with the patient's medical device.
  • the personal electronic device may include an application executed on the electronic device which communicatively links the device to the medical device. It is contemplated that such a communicative link may allow a remote party in possession of the linked electronic device to remotely control or otherwise transmit instructions effecting operation of the wearable medical device.
  • the user of such electronic device may use the electronic device to affirmatively transmit instructions remotely causing the control circuit in the medical device to activate and take corrective action, such as injecting a medication or stopping injection of a medication.
  • the remote party may be chosen from any emergency contacts or caregivers selected by a patient.
  • one remote party may be the patient's spouse, communicatively linked to the patient's medical device via a smart phone, laptop or home computer.
  • Another remote party may be a primary care physician communicatively linked to the patient's medical device via a computer.
  • Yet another remote party may be a friend or coworker of the patient communicatively linked to the patient's medical device via any of his or her own personal electronic devices such as a mobile phone or personal, laptop or tablet computer.
  • remote parties may be chosen based on the particular needs of the patient owing consideration to, for example, the severity of the patient's condition, the particular need for immediate response to monitored conditions, the extent of possible injury as consequence of the patient's condition, and the patient's personal desire for additional independence and/or security.
  • the medical device is a glucose monitor.
  • the glucose monitor may report that a patient's blood glucose levels have fallen below healthy levels. In one embodiment, this may mean that the patient's glucose monitor measures blood glucose levels below 70 mg/dl.
  • the glucose monitor may be programmed to report levels that are unhealthy on an individualized basis.
  • a user in possession of the personal electronic device may remotely instruct the medical device to effect corrective action.
  • corrective action may be causing any insulin delivery to stop. Corrective action may also be to automatically deliver glucose or Glucagon injections.
  • a remote party may aid treatment of a patient even when such party is geographically distanced from the patient.
  • a patient wearing an insulin and/or glucose pump may be prevented from experiencing inconvenient or even life threatening hypo or hyperglycemic episodes as a remote party in possession of a communicatively linked electronic device is able to remotely command therapeutic treatment, such as by remotely instructing relevant medical devices to begin or end delivery of insulin or glucose to the patient as the case may be.
  • the medical device may be an electronically controlled aerosol dispenser so that a remote electronic device may electronically transmit instructions that cause a dose to be emitted or altered in terms of timing or volume.
  • the medical device may be even further operative to to transmit various data relating to a patient's condition, or bodily data, to the remote parties in possession of any communicatively linked electronic devices.
  • the medical device may be operative to transmit a patient's heart rate and temperature.
  • the medical device may even be configured to transmit the location of the patient to the electronic devices so that, if needed, aid may be efficiently dispatched or rendered in-person.
  • the medical device may be further operative to transmit any sounds in the vicinity of the patient.
  • a remote party may be able to assess the quality of a patient's breathing, that is whether it is unusually labored or shallow.
  • Such exemplary and non-limiting features may aid remote parties having personal electronic devices in communication with the medical device in locating a possibly distressed patient as well as timely asserting diagnosis in case of medical distress or incapacitation.
  • FIG. 1 is a block diagram of a networked environment in which an exemplary embodiment of a system for remotely monitoring and controlling an electronic device is implemented;
  • FIG. 2 illustrates an exemplary embodiment of a mobile device shown in FIG. 1 operative to remotely communicate with a medical device.
  • FIG. 3A is a flowchart depicting an exemplary embodiment of a method for remotely monitoring and controlling an electronic device as may be performed by the systems shown in FIGS. 1 and 2 ;
  • FIG. 3B is another flowchart depicting an exemplary embodiment of a method for remotely monitoring and controlling an electronic device as may be performed by the systems shown in FIGS. 1 and 2 ;
  • FIG. 4 illustrates an exemplary embodiment of an electronic device shown in FIG. 1 ;
  • FIG. 5 illustrates an exemplary embodiment of a medical device shown in FIG. 1 .
  • One embodiment of the invention is implemented as a program product for use with a computer system.
  • the program(s) of the program product defines functions of the embodiments (including the methods described herein) and can be contained on a variety of computer-readable storage media.
  • Illustrative computer-readable storage media include, but are not limited to: (i) non-writable storage media (e.g., read-only memory devices within a computer such as CD-ROM disks readable by a CD-ROM drive) on which information is permanently stored; (ii) writable storage media (e.g., floppy disks within a diskette drive or hard-disk drive) on which alterable information is stored.
  • Such computer-readable storage media when carrying computer-readable instructions that direct the functions of the present invention, are embodiments of the present invention.
  • Other media include communications media through which information is conveyed to a computer, such as through a computer or telephone network, including wireless communications networks. The latter embodiment specifically includes transmitting information to/from the Internet and other networks.
  • Such communications media when carrying computer-readable instructions that direct the functions of the present invention, are embodiments of the present invention.
  • computer-readable storage media and communications media may be referred to herein as computer-readable media.
  • routines executed to implement the embodiments of the invention may be part of an operating system or a specific application, component, program, module, object, or sequence of instructions.
  • the computer program of the present invention typically is comprised of a multitude of instructions that will be translated by the native computer into a machine-readable format and hence executable instructions.
  • programs are comprised of variables and data structures that either reside locally to the program or are found in memory or on storage devices.
  • various programs described hereinafter may be identified based upon the application for which they are implemented in a specific embodiment of the invention. However, it should be appreciated that any particular program nomenclature that follows is used merely for convenience, and thus the invention should not be limited to use solely in any specific application identified and/or implied by such nomenclature.
  • Couple should be broadly understood and refer to connecting two or more elements or signals, electrically, mechanically or otherwise.
  • Two or more electrical elements may be electrically coupled, but not mechanically or otherwise coupled; two or more mechanical elements may be mechanically coupled, but not electrically or otherwise coupled; two or more electrical elements may be mechanically coupled, but not electrically or otherwise coupled.
  • Coupling (whether mechanical, electrical, or otherwise) may be for any length of time, e.g., permanent or semi-permanent or only for an instant.
  • FIG. 1 is an illustrative embodiment of a networked environment in which an exemplary embodiment of a system for remotely controlling and monitoring an electronic device is implemented.
  • the system 100 may comprise a plurality of electronic devices 102 , 104 shown, for example only and not limitation, as mobile smart phones. It is contemplated, however, that the electronic devices may be any computing device operative to transmit and receive data over any of one or more various communication network types, including, for example cellular and Wi-Fi communications.
  • the system 100 further comprises an electronic device 106 such as an electronic wearable medical device.
  • the medical device 106 is operative to dispense therapeutic doses of certain prescribed treatments.
  • one medical device 106 may be an insulin pump, a glucose or Glucagon pump, a combination of the two, or even a pump for other types of hormones.
  • Such devices are known in the art and may comprise an electronic control circuit housed in the medical device to optionally activate or deactivate such medical device, effectively delivering a prescribed dose of treatment into the body of the patient. Activation of the electronic control circuit may occur when a patient presses a button on the housing, or on a remote control electronically communicating with the medical device.
  • the device may even be programmed to regularly dispense dosages at a prescribed time.
  • the medical device 106 may be further operative to collect bodily data, such as any of blood glucose levels, heart rate, respiratory rate, and temperature.
  • bodily data such as any of blood glucose levels, heart rate, respiratory rate, and temperature.
  • the aforementioned exemplary pumps may comprise monitors such as glucose monitors in communication with said pumps. It is contemplated, however, that a patient may alternatively manually collect bodily data, which may be digitally stored and transmitted via the system 100 to a remote party communicatively linked in the treatment network and still benefit from remote monitoring and control as disclosed.
  • the electronic device 102 , 104 may be communicatively linked to an intermediate electronic device such as a remote control, which is itself communicatively linked to the wearable medical device via Bluetooth, RFID and other proximity-dependent wireless and even wired systems, however, these are known in to those skilled in the art.
  • a remote control which is itself communicatively linked to the wearable medical device via Bluetooth, RFID and other proximity-dependent wireless and even wired systems, however, these are known in to those skilled in the art.
  • the elements will be discussed generally as the medical device.
  • the invention may be worn permanently to practice the invention.
  • Many electronic wearable medical devices may be periodically removed, in fact, for charging and even for the patient's personal comfort.
  • Users of electronic devices 102 , 104 and medical device 106 may create their own private treatment network 110 in which to monitor, and eventually diagnose and treat, the patient's condition.
  • the network 110 enables members to use their users of electronic devices 102 and 104 to communicate with each other regarding the patient's condition.
  • a parent may manage their child patient's treatment and use their electronic device, operative to receive bodily data from the child's medical device, to communicate the child's condition or to manually transmit additional data to the child's physician, in possession of another of the electronic devices so that the physician and parent are able to interact with each other regarding the child's treatment.
  • a plurality of electronic devices may be in control of different medical specialists, each monitoring the patient's condition.
  • the treatment network 110 may be facilitated by a website or web-based application that may require a registration and login prior to use. Indeed, it is contemplated that owing to the sensitive nature of medical conditions and requirements for maintaining patient privacy, credentials and consent to join the network may be required. In the event that transmissions occur over a cellular network, rather than website or web-based application, it is contemplated that providing a predetermined code or even phone number may be sufficient to establish membership in the network. Regardless of how such a treatment network is implemented (be it web-based or not), the functionality of concern involves the ability to provide interaction among a limited group of members, as may be established by the members themselves.
  • the system 100 provides a better and more coordinated way of monitoring a patient's medical condition and remotely ensuring that he or she is able to receive proper treatment.
  • the system 100 enables a patient to transmit a request for treatment from their medical device 106 which may be received by any or one of the electronic devices in the treatment network 110 .
  • a remote party using the electronic device 102 , 104 may in turn transmit instructions causing the medical device 106 to dispense treatment. This may be further aided by the remote party's consideration for any bodily data which may have been collected and/or transmitted from the medical device 106 as well.
  • a patient may recognize that their lightheadedness and rapid heartbeat, or other symptoms, may be an early sign of a hypoglycemic episode but be unsure of their ability to treat the condition with food or drink or prescribed tablets.
  • the patient may then use their medical device 106 to request treatment.
  • Bodily data such as current or recent blood sugar levels, may in some embodiments be or have already been transmitted to other members, or remote parties, in the treatment network 110 , and be used by a remote party to determine whether remote treatment is warranted. If it is, the remote party may send instructions to remotely activate the medical device 106 so that it may deliver a therapeutic dose of, in the exemplary case glucose or Glucagon, into the body of the patient.
  • Confirmation may be transmitted by the medical device 106 to let the remote party know that remote treatment was successful. Confirmation may take place in one or two steps, or even more, such as via digital confirmation as a text message and also through prompting a phone call, though the exact method of confirmation is not dispositive.
  • system 100 receives information corresponding to the location of the patient.
  • this information may be collected by a mobile device 102 , 104 or 106 from integrated positioning technology, such as a Global Positioning System (GPS).
  • GPS Global Positioning System
  • various methods of determining the location of a mobile device can be used. This may be particularly desirous in cases where a patient's condition may result in unconsciousness or other incapacitation.
  • the medical device 106 may be operative to transmit ambient sounds to remote parties in the treatment network 110 . This may allow a patient to describe or otherwise automatically transmit audible evidence of their location and symptoms in real time.
  • electronic devices 102 , 104 , and medical device 106 include a patient monitoring and treatment system 100 , which can be implemented in numerous ways such as, for example and without limitation, an application executed on an electronic device.
  • FIG. 2 illustrates an alternative networked environment in which another exemplary embodiment of a system for controlling and monitoring an electronic device is implemented.
  • system 200 comprises by way of example, and not limitation, two electronic devices 202 and 204 and one electronic wearable medical device 206 communicatively coupled via a communication network 210 .
  • Each of the electronic devices 202 and 204 may be embodied as a mobile computing device such as, for example and without limitation, a smartphone that incorporates cellular telephone functionality.
  • the communications network can use one or more of various communications types such as, for example and without limitation, cellular and Wi-Fi communications.
  • the treatment network is facilitated by a website that is hosted by treatment network server 420 .
  • server 420 facilitates interaction among a limited group of members, as may be established by the members themselves. More particularly, the limited group of members may be chosen or managed or otherwise approved by the patient himself, owing of course to the sensitive nature medical diagnosis and treatment, as discussed with reference to the network in FIG. 1 above.
  • the limited group of members includes the users of electronic devices 402 and 404 .
  • server 220 implements the system for controlling and monitoring an electronic device and facilitates sharing information related to treatments with the patient amongst members of the treatment network, as permitted by the patient and laws relating to patient confidentiality, where applicable. Specifically, the server 220 implements the steps outlined in FIG. 3 .
  • FIGS. 3A and 3B are flowcharts depicting an exemplary embodiment of a system and method for invention such as may be performed by electronic devices 202 and 204 , and medical device 206 of FIG. 2 .
  • the method includes the steps of, at the medical device 106 : collecting bodily data characterizing the patient's condition (block 302 ); transmitting the collected bodily data (block 304 ); and transmitting a request for remote treatment (block 306 ).
  • a request for remote treatment may occur automatically. This may be desirable in the event that the medical device measures unsafe bodily data, as compared to predetermined threshold amounts.
  • the medical device may determine that the patient's blood sugar may be dangerously high or low and thus automatically transmit a request for remote treatment to members of the treatment network. An affirmative request for treatment may also occur, however. For instance, a patient may note unusual physiological effects of a certain meal and use their medical device to transmit a request for remote treatment, triggering remote prophylactic treatment by a remote party member of the treatment network.
  • the method may further include, at the medical device: initiating delivery of therapeutic treatment (block 308 ) to the patient; and transmitting confirmation that treatment was delivered (block 310 ).
  • the method includes the steps of, at an electronic device in possession of a member of the treatment network remote from the patient: receive bodily data characterizing the patient's condition (block 312 ); receive a request for treatment (block 314 ); enabling a determination that remote treatment is needed (block 316 ); transmitting instructions to the medical device to dispense therapeutic prescription (block 318 ); and receive confirmation that treatment was delivered (block 320 ).
  • FIGS. 3A and 3B may be similarly performed by electronic devices 102 and 104 , and medical device 106 of FIG. 1 .
  • a member of the treatment network can access the server 220 using their electronic devices 202 and 204 to review any received bodily data and determine whether to transmit remote instructions to dispense treatment, or use their medical device 406 to collect and transmit bodily data and request remote treatment, as the case may be.
  • various aspects may be performed by one or more of the electronic devices 202 , 204 or the medical device 206 .
  • the electronic devices 202 , 204 and/or medical devices 206 are operative to perform, at least in part, the method depicted in the flowchart of FIG. 3 , discussed above.
  • system 430 may also or alternatively be operative to perform, at least in part, the method depicted in the flowchart of FIG. 3 .
  • each block depicted in the accompanying flowcharts represents a module, segment, or portion of code that comprises program instructions stored on a non-transitory computer readable medium to implement the specified logical function(s).
  • the program instructions may be embodied in the form of source code that comprises statements written in a programming language or machine code that comprises numerical instructions recognizable by a suitable execution system such as the electronic device 102 , 104 , 402 and 404 and medical devices 106 and 206 .
  • the machine code may be converted from the source code, etc.
  • each block may represent a circuit or a number of interconnected circuits to implement the specified logical function(s).
  • the flowcharts show specific orders of execution, it is to be understood that the orders of execution may differ.
  • FIG. 4 illustrates one embodiment electronic device 102 shown in FIG. 1 . It is to be understood that such architecture may similarly, though not necessarily, define electronic device 104 and electronic devices 202 and 204 of FIG. 2 .
  • the foregoing is offered by way of example only, and not of limitation. One skilled in the art will recognize that a wide breadth of electronic devices, variously configured, may be used without departing from the invention.
  • the electronic device 102 may be a tablet, desktop, or laptop computer or smartphone but may also be embodied in any one of a wide variety of wired and/or wireless computing devices. As shown in FIG. 4 , electronic device 102 includes a processing device (processor) 402 , input/output interfaces 404 , a display 406 , a touchscreen interface 408 , a network interface 410 , a memory 412 , and operating system 414 , a mass storage 416 and an GPS 418 , with each communicating across a local data bus 420 . Additionally, electronic device 102 incorporates a system controlling and monitoring an electronic device 100 , which is depicted as including bodily data 422 , and perhaps even treatment history and other patient information, though the location of 422 .
  • processor processing device
  • the processing device 402 may include any custom made or commercially available processor, a central processing unit (CPU) or an auxiliary processor among several processors associated with the electronic device 102 , a semiconductor based microprocessor (in the form of a microchip), a macroprocessor, one or more application specific integrated circuits (ASICs), a plurality of suitably configured digital logic gates, and other electrical configurations comprising discrete elements both individually and in various combinations to coordinate the overall operation of the system.
  • CPU central processing unit
  • ASICs application specific integrated circuits
  • the memory 412 can include any one of a combination of volatile memory elements (e.g., random-access memory (RAM, such as DRAM, and SRAM, etc.)) and nonvolatile memory elements.
  • the memory typically comprises native operating system 414 , one or more native applications, emulation systems, or emulated applications for any of a variety of operating systems and/or emulated hardware platforms, emulated operating systems, etc.
  • the applications may include application specific software which may comprise some or all the components of the mobile device 102 .
  • the components are stored in memory and executed by the processing device. Note that although depicted separately in FIG. 4 , the system and method for controlling and monitoring an electronic device 100 may be resident in memory such as memory 412 .
  • Touchscreen interface 408 is configured to detect contact within the display area of the display 406 and provides such functionality as on-screen buttons, menus, keyboards, etc. that allows users to navigate user interfaces by touch.
  • the electronic device 102 will comprise GPS 418 or other means to determine the location of the electronic device 102 .
  • a non-transitory computer-readable medium stores one or more programs for use by or in connection with an instruction execution system, apparatus, or device.
  • network interface device 310 comprises various components used to transmit and/or receive data over a networked environment such as depicted in FIG. 1 .
  • the one or more components may be stored on a non-transitory computer-readable medium and executed by the processing device.
  • FIG. 5 includes, for example, a processing device (processor) 502 , input/output interfaces 504 , a display 506 , a touchscreen interface 508 , a network interface 510 , a memory 512 , and operating system 514 , a mass storage 516 and an GPS 518 , with each communicating across a local data bus 520 with the addition of pump or control 524 in communication with the processor.
  • processor processing device
  • embodiments and limitations disclosed herein are not dedicated to the public under the doctrine of dedication if the embodiments and/or limitations: (1) are not expressly claimed in the claims; and (2) are or are potentially equivalents of express elements and/or limitations in the claims under the doctrine of equivalents.
US15/285,774 2016-10-05 2016-10-05 Method, system, and apparatus for remotely controlling and monitoring an electronic device Active 2037-05-27 US10987032B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US15/285,774 US10987032B2 (en) 2016-10-05 2016-10-05 Method, system, and apparatus for remotely controlling and monitoring an electronic device
EP17857709.4A EP3522950A4 (fr) 2016-10-05 2017-08-02 Procédé, système et appareil pour commande et surveillance à distance d'un dispositif électronique
PCT/BR2017/050217 WO2018064733A1 (fr) 2016-10-05 2017-08-02 Procédé, système et appareil pour commande et surveillance à distance d'un dispositif électronique
BR112019006808A BR112019006808A2 (pt) 2016-10-05 2017-08-02 método e sistema para controlar e monitorar remotamente um dispositivo eletrônico, e, meio legível por computador tangível não transitório.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/285,774 US10987032B2 (en) 2016-10-05 2016-10-05 Method, system, and apparatus for remotely controlling and monitoring an electronic device

Publications (2)

Publication Number Publication Date
US20180092576A1 US20180092576A1 (en) 2018-04-05
US10987032B2 true US10987032B2 (en) 2021-04-27

Family

ID=61757389

Family Applications (1)

Application Number Title Priority Date Filing Date
US15/285,774 Active 2037-05-27 US10987032B2 (en) 2016-10-05 2016-10-05 Method, system, and apparatus for remotely controlling and monitoring an electronic device

Country Status (4)

Country Link
US (1) US10987032B2 (fr)
EP (1) EP3522950A4 (fr)
BR (1) BR112019006808A2 (fr)
WO (1) WO2018064733A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11581080B2 (en) 2020-12-07 2023-02-14 Beta Bionics, Inc. Ambulatory medicament pump voice operation
US11587664B2 (en) 2020-12-07 2023-02-21 Beta Bionics, Inc. Glucose level control system with therapy customization
USD980857S1 (en) 2020-03-10 2023-03-14 Beta Bionics, Inc. Display screen with graphical user interface
US11925788B2 (en) 2020-12-07 2024-03-12 Beta Bionics, Inc. Ambulatory medicament device with motion detection and gesture-based control
US11941392B2 (en) 2019-07-16 2024-03-26 Beta Bionics, Inc. Ambulatory medical device with malfunction alert prioritization
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
EP3258991B1 (fr) 2015-02-18 2020-10-21 Insulet Corporation Dispositifs de perfusion et de distribution de fluide, et leurs procédés d'utilisation
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
WO2018058041A1 (fr) 2016-09-23 2018-03-29 Insulet Corporation Dispositif d'administration de fluide avec capteur
WO2018132765A1 (fr) 2017-01-13 2018-07-19 Mazlish Bryan Procédés, systèmes et dispositifs d'administration d'insuline
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
EP3856285A1 (fr) 2018-09-28 2021-08-04 Insulet Corporation Mode d'activité pour système de pancréas artificiel
WO2020077223A1 (fr) 2018-10-11 2020-04-16 Insulet Corporation Détection d'événement pour système d'administration de médicament
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4069082A1 (fr) 2019-12-06 2022-10-12 Insulet Corporation Techniques et dispositifs de fourniture d'adaptabilité et de personnalisation dans le traitement du diabète
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US20230017775A1 (en) * 2021-07-15 2023-01-19 Invacare Corporation System and method for medical device communication
WO2023049900A1 (fr) 2021-09-27 2023-03-30 Insulet Corporation Techniques permettant l'adaptation de paramètres dans des systèmes d'aide par entrée d'utilisateur
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558640A (en) * 1994-03-17 1996-09-24 Siemens Aktiengesellschaft System for infusion of medicine into the body of a patient
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
US6589169B1 (en) * 1998-03-13 2003-07-08 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients undergoing anticoagulation therapy
US20040078220A1 (en) * 2001-06-14 2004-04-22 Jackson Becky L. System and method for collection, distribution, and use of information in connection with health care delivery
US20070185736A1 (en) * 2006-02-07 2007-08-09 Eflag Professional Solutions, Llc Systems, methods, and computer program products for facilitating communications, workflow, and task assignments in medical practices and clinics
US20090088088A1 (en) * 2007-02-28 2009-04-02 Crick Information Technologies Personal Information Communication Device and Method
US20110082711A1 (en) * 2009-10-06 2011-04-07 Masimo Laboratories, Inc. Personal digital assistant or organizer for monitoring glucose levels
US20110320130A1 (en) * 2010-06-25 2011-12-29 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices
US20120108991A1 (en) * 2010-10-29 2012-05-03 Medtronic, Inc. Ischemia detection and classification
US20120154157A1 (en) * 2010-12-21 2012-06-21 Moses George Sensor to detect an emergency event
US20120189140A1 (en) * 2011-01-21 2012-07-26 Apple Inc. Audio-sharing network
US20120191061A1 (en) * 2009-06-04 2012-07-26 Ofer Yodfat Devices and methods for adjusting basal delivery profile
US20120238853A1 (en) * 2010-08-18 2012-09-20 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US20140180203A1 (en) * 2009-05-22 2014-06-26 Abbott Diabetes Care Inc. Integrated insulin delivery system having safety features to prevent hypoglycemia
US20140278552A1 (en) * 2013-03-15 2014-09-18 Global Telehealth Solutions, Inc. Modular centralized patient monitoring system
US20150073393A1 (en) * 2009-07-09 2015-03-12 Medtronic Minimed, Inc. Coordination of control commands and controller disable messages in a medical device system
US20160113565A1 (en) * 2009-08-28 2016-04-28 Samsung Electronics Co., Ltd. Method and apparatus for recommending a route
US20160210429A1 (en) * 2015-01-05 2016-07-21 Luis M. Ortiz Systems and methods for medical patient treatment tracking, provider-patient association, and record integration
US20160263317A1 (en) * 2013-02-22 2016-09-15 Thuban, Inc. Device for enabling patient self-testing and treatment self-adminstration and system using the device for managing the patient's health care
US20170076052A1 (en) * 2014-05-15 2017-03-16 Emory University Methods and systems for dynamic management of a health condition
US20170200050A1 (en) * 2016-01-12 2017-07-13 Xiaoyi Technology Co., Ltd. System and method for previewing video

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027829A1 (fr) * 1996-01-31 1997-08-07 The Trustees Of The University Of Pennsylvania Dispositif d'administration de medicament commande a distance
US6464687B1 (en) * 1999-03-09 2002-10-15 Ball Semiconductor, Inc. Implantable drug delivery system
EP2572740A1 (fr) * 2011-09-20 2013-03-27 Roche Diagnostics GmbH Dispositifs d'injection de médicaments et systèmes avec un module de mesure de substance à analyser
US20140213998A1 (en) * 2013-01-30 2014-07-31 Glucome Ltd. System and method for administering insulin
US10004435B2 (en) * 2013-11-14 2018-06-26 Dexcom, Inc. Devices and methods for continuous analyte monitoring
US20150173674A1 (en) * 2013-12-20 2015-06-25 Diabetes Sentry Products Inc. Detecting and communicating health conditions
CN107073207B (zh) * 2014-08-01 2020-03-20 伯克顿迪金森公司 连续葡萄糖监测注射装置
JP6901395B2 (ja) * 2015-02-10 2021-07-14 デックスコム・インコーポレーテッド 連続的グルコースデータを配信するためのシステム及び方法

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558640A (en) * 1994-03-17 1996-09-24 Siemens Aktiengesellschaft System for infusion of medicine into the body of a patient
US6589169B1 (en) * 1998-03-13 2003-07-08 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients undergoing anticoagulation therapy
US20030060765A1 (en) * 2000-02-16 2003-03-27 Arthur Campbell Infusion device menu structure and method of using the same
US20040078220A1 (en) * 2001-06-14 2004-04-22 Jackson Becky L. System and method for collection, distribution, and use of information in connection with health care delivery
US20070185736A1 (en) * 2006-02-07 2007-08-09 Eflag Professional Solutions, Llc Systems, methods, and computer program products for facilitating communications, workflow, and task assignments in medical practices and clinics
US20090088088A1 (en) * 2007-02-28 2009-04-02 Crick Information Technologies Personal Information Communication Device and Method
US20140180203A1 (en) * 2009-05-22 2014-06-26 Abbott Diabetes Care Inc. Integrated insulin delivery system having safety features to prevent hypoglycemia
US20120191061A1 (en) * 2009-06-04 2012-07-26 Ofer Yodfat Devices and methods for adjusting basal delivery profile
US20150073393A1 (en) * 2009-07-09 2015-03-12 Medtronic Minimed, Inc. Coordination of control commands and controller disable messages in a medical device system
US20160113565A1 (en) * 2009-08-28 2016-04-28 Samsung Electronics Co., Ltd. Method and apparatus for recommending a route
US20110082711A1 (en) * 2009-10-06 2011-04-07 Masimo Laboratories, Inc. Personal digital assistant or organizer for monitoring glucose levels
US20110320130A1 (en) * 2010-06-25 2011-12-29 Dexcom, Inc. Systems and methods for communicating sensor data between communication devices
US20120238853A1 (en) * 2010-08-18 2012-09-20 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US20120108991A1 (en) * 2010-10-29 2012-05-03 Medtronic, Inc. Ischemia detection and classification
US20120154157A1 (en) * 2010-12-21 2012-06-21 Moses George Sensor to detect an emergency event
US20120189140A1 (en) * 2011-01-21 2012-07-26 Apple Inc. Audio-sharing network
US20160263317A1 (en) * 2013-02-22 2016-09-15 Thuban, Inc. Device for enabling patient self-testing and treatment self-adminstration and system using the device for managing the patient's health care
US20140278552A1 (en) * 2013-03-15 2014-09-18 Global Telehealth Solutions, Inc. Modular centralized patient monitoring system
US20170076052A1 (en) * 2014-05-15 2017-03-16 Emory University Methods and systems for dynamic management of a health condition
US20160210429A1 (en) * 2015-01-05 2016-07-21 Luis M. Ortiz Systems and methods for medical patient treatment tracking, provider-patient association, and record integration
US20170200050A1 (en) * 2016-01-12 2017-07-13 Xiaoyi Technology Co., Ltd. System and method for previewing video

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11941392B2 (en) 2019-07-16 2024-03-26 Beta Bionics, Inc. Ambulatory medical device with malfunction alert prioritization
US11957876B2 (en) 2019-07-16 2024-04-16 Beta Bionics, Inc. Glucose control system with automated backup therapy protocol generation
USD980857S1 (en) 2020-03-10 2023-03-14 Beta Bionics, Inc. Display screen with graphical user interface
USD980858S1 (en) 2020-03-10 2023-03-14 Beta Bionics, Inc. Display screen with transitional graphical user interface
USD981439S1 (en) 2020-03-10 2023-03-21 Beta Bionics, Inc. Display screen with animated graphical user interface
US11581080B2 (en) 2020-12-07 2023-02-14 Beta Bionics, Inc. Ambulatory medicament pump voice operation
US11587664B2 (en) 2020-12-07 2023-02-21 Beta Bionics, Inc. Glucose level control system with therapy customization
US11610661B2 (en) 2020-12-07 2023-03-21 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US11610662B2 (en) 2020-12-07 2023-03-21 Beta Bionics, Inc Medicament pumps and control systems for managing glucose control therapy data of a subject
US11688501B2 (en) 2020-12-07 2023-06-27 Beta Bionics, Inc. Ambulatory medicament pump with safe access control
US11925788B2 (en) 2020-12-07 2024-03-12 Beta Bionics, Inc. Ambulatory medicament device with motion detection and gesture-based control

Also Published As

Publication number Publication date
BR112019006808A2 (pt) 2019-07-09
WO2018064733A1 (fr) 2018-04-12
EP3522950A1 (fr) 2019-08-14
US20180092576A1 (en) 2018-04-05
EP3522950A4 (fr) 2020-05-27

Similar Documents

Publication Publication Date Title
US10987032B2 (en) Method, system, and apparatus for remotely controlling and monitoring an electronic device
US10758670B2 (en) Diabetes management system
DE112020003406T5 (de) Blutzuckerkontrollsystem
US20200237298A1 (en) Hypoglycemic Treatment Methods And Systems
US11911590B2 (en) Integration of infusion pump with remote electronic device
US9491277B2 (en) Computerized method and system for global health, personal safety and emergency response
US10772556B2 (en) Method and system for monitoring and treating hypoglycemia
US20210272672A1 (en) Personalized pain management method, device and computer program
US9208288B2 (en) System and method for remote patient monitoring and assessment to facilitate patient treatment
JP2022501139A (ja) 人工膵臓システム用活動モード
JP6730928B2 (ja) 治療薬剤注入器機を制御するハンドセット機との間の送受信の管理
US20140025392A1 (en) Systems and Methods for Validating Treatment Instructions
US20160085937A1 (en) Care plan administration using thresholds
EP3197534B1 (fr) Activation contextuelle de produits pharmaceutiques au moyen de dispositifs portables
KR101859364B1 (ko) 인슐린 펌프의 동작 상태를 검사하기 위한 양방향 통신을 갖는 원격 펌프 제어기
BRPI0720856A2 (pt) Sistema de alerta de emergência móvel
DE112020004762T5 (de) Blutzuckerkontrollsystem
US20170014028A1 (en) Medical monitoring and treatment devices, systems, and methods
KR20160054320A (ko) 스마트폰을 이용한 혈당 관리 시스템
US11823782B2 (en) Systems, methods, apparatuses, and computer program products for administering pain management solutions remotely
US20230166035A1 (en) Emergency medicament dose control
US20240024578A1 (en) Ambulatory medicament pump with distress notifications
US20230337949A1 (en) Ambulatory medicament pump with distress notifications
US20230298724A1 (en) Ambulatory medicament pump with training notifications
US20240090854A1 (en) Wearable medical device system with caregiver notifications

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

STCC Information on status: application revival

Free format text: WITHDRAWN ABANDONMENT, AWAITING EXAMINER ACTION

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE